Vertex shells out $950 million to acquire a company working on a diabetes cure
8:18am PDT - September 6th, 2019 daily search trends - Business InsiderThis is an excerpt from a story delivered exclusively to Business Insider Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here. Boston-based Vertex Pharmaceuticals, maker of a suite of cystic fibr…